Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00883714
NCT00883714UnknownPhase 3

Exercise During the Allogeneic Stem Cell Transplantation

Charite University, Berlin, Germany2 sites in 1 country60 target enrollmentStarted: May 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 3
Enrollment
60
Locations
2
Primary Endpoint
VO2max
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The study will evaluate the effects of a structured endurance exercise program on the physical performance, the mood and the complications of patients with hematological malignancies undergoing a high-dose chemotherapy followed by an allogeneic peripheral blood stem cell transplantation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Neoplastic malignancy
  • •Allogeneic peripheral stem cell transplantation
  • •Proficiency in German

Exclusion Criteria

  • •Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise
  • •Pathological stress-ECG at admission

Outcomes

Primary Outcomes

VO2max

Time Frame: At recruitment and after 4 weeks

Secondary Outcomes

  • Mood(At recruitment and after 4 weeks)
  • Complications(4 weeks)
  • Requirement for blood and platelets transfusions(4 weeks)

Investigators

Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials

Completed
Not Applicable
Fitness in Allogeneic Stem Cell TransplantationHematopoietic Stem Cell Transplantation
NCT02564458UNC Lineberger Comprehensive Cancer Center35
Recruiting
Not Applicable
Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological MalignancyHaematological Malignancy
NCT05379738Centre Hospitalier Universitaire de Nice75
Completed
Phase 2
Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCTMultiple Myeloma
NCT00599495Universitätsklinikum Hamburg-Eppendorf50
Unknown
Not Applicable
Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autograft (APA²)MyelomaAutologous TransplantLymphoma
NCT04320420Weprom57
Unknown
Phase 2
Exercise for Patients With HIV InfectionsLipodystrophyInflammationHIV Infections
NCT00910936Charite University, Berlin, Germany60